Current pharmacological treatments for COPD primarily rely on bronchodilators (LABA/LAMA), inhaled corticosteroids (ICS), and phosphodiesterase-4 inhibitors (PDE4-Is), which aim to relieve symptoms and reduce exacerbations [50]. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.